Implicating this pathway further, a blinded analysis of peripheral blood of patients following BMT revealed a correlation between decreased CD36 expression and CD141+ DCs (the human equivalent of CD8α+ cDC1s) with increased frequency of GVHD development, despite no significant differences in prevalence of other cell types, demographic, or clinical characteristics. This evidence concerns the gene CD36 and graft versus host disease.